Navigation Links
Minerva and Cymbalta Patent Invalidity Evidence Uncovered by Article One Partners Community
Date:9/21/2009

NEW YORK, Sept. 21 /PRNewswire/ -- Article One Partners, LLC has discovered new prior art impacting the validity of two Minerva Industries, Inc. patents for mobile entertainment and communications devices. Article One also announced the discovery of new evidence which can show Eli Lilly & Company's patent for Cymbalta to be invalid, as verified by outside counsel. The discovery of this patent validity evidence can impact the industry litigation and continued innovation surrounding both cases.

"With Minerva, a non-practicing entity filed suit against an entire industry. And with Cymbalta, the patent has been asserted to prevent generic drug manufacturing. Both are great examples of patent disputes where the true cost is born by the public," said Cheryl Milone, founder and CEO of Article One Partners. "Article One Partners not only allows the public to weigh in directly, but provides rewards for a citizen review of the patent system. The community helps ensure the validity of patents that are being widely enforced."

Minerva Industries, Inc. filed a lawsuit on January 22, 2008, alleging that Nokia, Palm and more than 30 cell phone manufacturers and providers infringed on its U.S. Patents for "Mobile Entertainment and Communication Device" (Patent Nos. 6,681,120 and 7,321,783). The patents relate to add-on functional features for cellular phones and mobile devices. More than 200 references of prior art evidence were submitted by Advisors - members of the Article One Community. The key evidence was provided by three Advisors with usernames Columbo, Ramesh and Singh, who will share the monetary reward of $50,000.

Cymbalta is the brand name for a drug used in the treatment of depression. Patent holder Eli Lilly and Company has claimed infringement by Sandoz, Inc. and others. Lilly's Patent (U.S. Patent No. 5,023,269) covers a pharmaceutical composition including a selectiv
'/>"/>

SOURCE Article One Partners, LLC
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Lilly Resubmits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
2. Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R)
3. Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder
4. FDA Approves Cymbalta(R) for the Management of Fibromyalgia
5. Axiom Worldwide Convicted of Infringing a Hako-Med Patent
6. MedWaves, Inc. Sponsors Investigational Studies to Evaluate Its Patented Microwave Thermal Coagulation-Ablation System for Treatment of Tumors in Liver and Lung
7. GENova Biotherapeutics signs LOI with Korean university for stem cell research and patents sharing
8. Appeals Court Rules in Favor of Prometheus, Upholds the Patentability of Its Claims for Methods of Thiopurine Metabolite Testing
9. Milestone Scientific Receives Notice of Allowance From U.S. Patent and Trademark Office
10. Appeals Court Affirms Patent Infringement Rulings Against Roches peg-EPO Product
11. RZN Nutraceuticals Receives United States Patent & Trademark Office Notice of Allowance for Proprietary HerbaZorb(TM) Absorption and Delivery System Technology Used in Popular Arthri-Zen Relief(R) and Migra-Zen Relief PLUS(R) Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... -- 4R Systems, Inc., a leading provider of ... retailers significantly increase profits by optimizing their inventory ... The Vitamin Shoppe has been utilizing the 4R ... DC inventory solutions have helped us drive significant ... the last two years," said Tony Truesdale, President ...
(Date:12/15/2009)... Patient advocate Betsy McCaughey, Ph.D., ... that, "it doesn,t matter whether there,s a public option. ... public option - give government authority over how your ... new social agenda by shifting billions of dollars from ... immigrants, and local politicians." ,, Betsy McCaughey ...
(Date:12/15/2009)... CITY, Dec. 15 The new compact LifeSpan ... ( www.LifeSpanFitness.com ), was highly praised by ... treadmills for 2010. The compact TR200 folding treadmill received ... Best Treadmill under $1000. ,, The compact LifeSpan ... in small workout spaces. "This category buster is a ...
(Date:12/15/2009)... of 30 Individuals Charged in Miami, Detroit and ... Billing to Medicare ,, WASHINGTON, Dec. ... in three cities for their alleged roles in ... false Medicare claims as part of the continuing ... of Health and Human Services (HHS) Secretary Kathleen ...
(Date:12/15/2009)... chronic obstructive pulmonary disease, or COPD, with increased activity ... body,s immune system. , The University of Michigan ... the immune system,s role in COPD, a serious, progressive ... with wheezing, shortness of breath, chest tightening and other ... to find better ways to detect and treat the ...
Breaking Medicine News(10 mins):Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 3Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 4Health News:Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill 2Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 2Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 3Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 4Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 5Health News:Immune cell activity linked to worsening COPD 2Health News:Immune cell activity linked to worsening COPD 3
... Vue Clinic told the press that the clinic will be converted ... 30 crores is invested to transform this // clinic into a ... ,A plastic surgery unit is also to be opened under the ... ,He emphasized on the growing demand for plastic surgery as they ...
... that as many as 1,000 children in Venezuela may be ... have abandoned them, and they are forced to fend for ... that there are over 60 non-governmental organizations in the nation ... ensure that it does not spread, and contain it. ...
... new software helps in assisting the blood sugar level of ... the survival rates of critically ill patients. ,A ... Informatics and ,Decision Making, states that GRIP, computer software that ... patients, saves nurses time ,and effort and is more efficient ...
... University of Minnesota studied the blood pressure (BP) and eating habits ... were aged between 18 years and 30 years. An inverse connection ... fruit, nuts, whole grain, and milk, when in comparison to low ... reduced by 27% and 36% by the consumption of the second ...
... message that has been doing the rounds in Saudi Arabia ... was reportedly smuggled into the kingdom will harm the kidneys ... Health. ,The medicine provides relief from fever and ... aware of this issue for about 23 days. The Pharmacists ...
... The export of Ayurvedic medicines from India has suffered ... Government that has revealed alarmingly high levels of heavy ... than 18 different Ayurvedic medicines have been tested by ... health department. ,The analysis has highlighted ...
Other Medicine News:Health News:Export Of Ayurvedic Medicines Affected Due To High Heavy Metal Content 2
(Date:12/15/2009)... Harvard medical expert internationally recognized as a leading ... decision last month to suspend Doug Barron for ... having the medical condition hypogonadism and ... unfair and discriminatory." ,, Hypogonadism is ... often referred to informally as Low T ...
(Date:12/15/2009)... -- Fenwal Inc., a global medical technology company ... availability, announced today that the U.S. Food and ... InterSol ® platelet additive solution. Fenwal ... specialized product used in combination with human plasma ... used to prevent or treat bleeding. ,, InterSol ...
(Date:12/15/2009)... -- Reportlinker.com announces that a new market ... ,, Boehringer Ingelheim GmbH: PharmaVitae Profile ... Introduction ,, This analysis examines the ... in the Rx pharmaceutical sector. The profile ... and assessment of financial performance, with 1-6 ...
Breaking Medicine Technology:Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 2Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 3Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 4Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets 2Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 2Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 3Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 4Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 5Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 6Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 7Heart Attacks Less Often Fatal Today 49550 1Heart Attacks Less Often Fatal Today 49550 2Heart Attacks Less Often Fatal Today 49550 3EUROPACE raises remote monitoring profile 49546 1EUROPACE raises remote monitoring profile 49546 2EUROPACE raises remote monitoring profile 49546 3Governor Rendell Discusses Impact of Budget on Services for Families of Children With Autism 49543 1Governor Rendell Discusses Impact of Budget on Services for Families of Children With Autism 49543 2
... Scheduled for Friday, May 4, at 9:00 a.m.,Eastern ... 2007 /PRNewswire-FirstCall/ --,Medivation, Inc. today announced that new ... disease patients in the Company's,six-month Phase 2 efficacy ... compared with placebo-treated patients on,all five efficacy endpoints ...
... Homspera Shows Promise As an Adjuvant for ... Ariz., May 07, 2007 /PRNewswire-FirstCall/ -- IR,BioSciences ... its influenza vaccine adjuvant study being performed ... host,immune responsiveness above that induced by vaccine ...
Other Medicine Technology:Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 2Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 3Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 4Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 5IR BioSciences Announces Promising Data from Study of Its Compound,Homspera 2IR BioSciences Announces Promising Data from Study of Its Compound,Homspera 3IR BioSciences Announces Promising Data from Study of Its Compound,Homspera 4
... is an external fixator designed for the ... femur, tibia, humerus and forearm. , ,Indications ... fixation is the treatment of choice due ... Align is fully compatible with the Ace-Fischer ...
The DFS Standard Fixator advantages include a highly adjustable system, modular compression/distraction, versatile central body component that provides 360 of rotation, and a positive locking mechani...
The Adjustable Large Fixator is a one-piece fixator with a radiolucent body. It has a multifunctional design pivoting pin clamp for use in ankle or tibial plateau fractures....
Provides basic reduction capabilities for angulation, rotation and length. Ball joint design offers fracture reduction in all planes....
Medicine Products: